Cheng Andrew sold AKRO
September 11, 2025 · Form 4 insider transaction
Cheng Andrew sold 1,796 shares of Akero Therapeutics, Inc. at $43.02 per share, a transaction worth $77.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,796
Price
$43.02
Total value
$77.3K
InsiderCheng Andrew
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 11, 2025
Filing dateSeptember 12, 2025
Shares owned after473,902
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The Issuer has adopted a "sell-to-cover" policy to satisfy the tax withholding obligations of the Reporting Person. Such sales were automatic and not at the discretion of the Reporting Person.